The substance has long been investigated from the patent literature for its anxiolytic Houses and diminished sedative, hypnotic, and ataxic aspect-effects, but it does not appear to be licensed for medical use. Łukasik-Głebocka et alPyrazolam is actually a triazolo-BZD with apparently little or no details, structurally similar to alprazolam but i